Galectin-9 ameliorates clinical severity of MRL/lpr lupus-prone mice by inducing plasma cell apoptosis independently of Tim-3.
Galectin-9 ameliorates clinical severity of MRL/lpr lupus-prone mice by inducing plasma cell apoptosis independently of Tim-3.
复制标题
DOI:
10.1371/journal.pone.0060807
复制
发表时间:
2013
期刊:
影响因子:
3.7
通讯作者:
Hirashima M
中科院分区:
文献类型:
--
作者:
Moritoki M;Kadowaki T;Niki T;Nakano D;Soma G;Mori H;Kobara H;Masaki T;Kohno M;Hirashima M
Galectin-9 ameliorates various murine autoimmune disease models by regulating T cells and macrophages, although it is not known what role it may have in B cells. The present experiment shows that galectin-9 ameliorates a variety of clinical symptoms, such as proteinuria, arthritis, and hematocrit in MRL/lpr lupus-prone mice. As previously reported, galectin-9 reduces the frequency of Th1, Th17, and activated CD8+ T cells. Although anti-dsDNA antibody was increased in MRL/lpr lupus-prone mice, galectin-9 suppressed anti-dsDNA antibody production, at least partly, by decreasing the number of plasma cells. Galectin-9 seemed to decrease the number of plasma cells by inducing plasma cell apoptosis, and not by suppressing BAFF production. Although about 20% of CD19−/low CD138+ plasma cells expressed Tim-3 in MRL/lpr lupus-prone mice, Tim-3 may not be directly involved in the galectin-9-induced apoptosis, because anti-Tim-3 blocking antibody did not block galectin-9-induced apoptosis. This is the first report of plasma cell apoptosis being induced by galectin-9. Collectively, it is likely that galectin-9 attenuates the clinical severity of MRL lupus-prone mice by regulating T cell function and inducing plasma cell apoptosis.
登录
查看更多内容
影响因子:
5.1
作者:
Lee, Jaejoon;Park, Eun-Jung;Cha, Hoon-Suk
通讯作者:
Cha, Hoon-Suk
影响因子:
4.9
作者:
Dillon SR;Harder B;Lewis KB;Moore MD;Liu H;Bukowski TR;Hamacher NB;Lantry MM;Maurer M;Krejsa CM;Ellsworth JL;Pederson S;Elkon KB;Wener MH;Dall'Era M;Gross JA
通讯作者:
Gross JA
影响因子:
1.5
作者:
Kleczynska, Weronika;Jakiela, Bogdan;Musial, Jacek
通讯作者:
Musial, Jacek
影响因子:
27.4
作者:
Koyama, T;Tsukamoto, H;Horiuchi, T
通讯作者:
Horiuchi, T
DOI:
10.1084/jem.20081398
发表时间:
2008-11-24
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Jones RB;Ndhlovu LC;Barbour JD;Sheth PM;Jha AR;Long BR;Wong JC;Satkunarajah M;Schweneker M;Chapman JM;Gyenes G;Vali B;Hyrcza MD;Yue FY;Kovacs C;Sassi A;Loutfy M;Halpenny R;Persad D;Spotts G;Hecht FM;Chun TW;McCune JM;Kaul R;Rini JM;Nixon DF;Ostrowski MA
通讯作者:
Ostrowski MA